Study of EXE-346 Live Biotherapeutic to Reduce High Bowel Movement Frequency in Subjects With an IPAA (PROF)

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2023
The aim of this study is to assess the safety and preliminary efficacy of treatment with EXE-346, a live biotherapeutic, which may reduce bowel movement frequency in patients with an ileal pouch-anal anastomosis (IPAA) and lead to a higher quality of life.
Epistemonikos ID: 1e17ff1a02b45549cff87cbd4134e0ffce651e03
First added on: Oct 02, 2023